Wealth Enhancement Advisory Services’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$58.4K Sell
45,616
-30,041
-40% -$59K ﹤0.01% 4023
2026
Q2
$182K Buy
75,657
+25,936
+52% +$63.4K ﹤0.01% 3624
2026
Q1
$111K Buy
49,721
+14,177
+40% +$49.1K ﹤0.01% 3296
2025
Q4
$155K Buy
35,544
+772
+2% +$3.74K ﹤0.01% 3341
2025
Q3
$144K Buy
34,772
+449
+1% +$2.09K ﹤0.01% 3253
2025
Q2
$146K Sell
34,323
-9,075
-21% -$33.8K ﹤0.01% 3075
2025
Q1
$187K Buy
43,398
+4,239
+11% +$17.1K ﹤0.01% 2644
2024
Q4
$125K Buy
39,159
+5,551
+17% +$18.6K ﹤0.01% 2775
2024
Q3
$96.1K Buy
+33,608
New +$94.3K ﹤0.01% 2565

Other funds holding ORGO

Wealth Enhancement Advisory Services's ORGO Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Organogenesis Holdings (ORGO) stake by 40% in Q3 2026, selling an estimated $59K and leaving 45,616 shares worth $58.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4023.

Wealth Enhancement Advisory Services first reported a position in ORGO in Q3 2024 and has held it in 9 quarters since. The position peaked at $187K in Q1 2025. 119 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

  • Wealth Enhancement Advisory Services held 45,616 shares of Organogenesis Holdings worth $58.4K as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 30,041 Organogenesis Holdings shares in Q3 2026, an estimated $59K.
  • Organogenesis Holdings made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4023 holding.
  • Wealth Enhancement Advisory Services first reported a position in Organogenesis Holdings in Q3 2024 and has held it in 9 quarters since.
  • Wealth Enhancement Advisory Services's Organogenesis Holdings position peaked at $187K in Q1 2025.
  • 119 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.